CLINICAL IMPACT OF DEPRESSION ON TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS: A LITERATURE REVIEW
Authors:
- Maciej BłaszczakMBMaciej Błaszczak
- Wiktoria LejaWLWiktoria Leja
- Katarzyna LatalskaKLKatarzyna Latalska
- Zeeshan ZulfiqarZZZeeshan Zulfiqar
- Jakub KotJKJakub Kot
- Katarzyna CzechowiczKCKatarzyna Czechowicz
- Maciej SzczupajMSMaciej Szczupaj
- Andżelika PastuszakAPAndżelika Pastuszak
- Konrad BorkowskiKBKonrad Borkowski
- Jakub RudnickiJRJakub Rudnicki
Open Access
- 27 April 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Abstract
Depression is a common comorbidity in rheumatoid arthritis, however we still don't know enough about how it affects treatment outcomes. This systematic review aims to assess the clinical influence of depression on disease activity, remission rates, pharmacological treatment response, patient-reported outcomes, and treatment adherence behaviour in individuals with rheumatoid arthritis. A thorough literature review was performed using PubMed, Scopus and Web of Science. We focused on studies published from 2020 to 2026 that evaluated depressive symptoms through validated instruments and reported at least one treatment-related outcome. The results consistently indicated that comorbid depression correlated with greatly elevated composite disease activity scores. It was mostly influenced by subjective rather than objective components. Patients exhibiting depressive symptoms were less likely to attain remission and demonstrated diminished responses to both conventional synthetic and biologic disease-modifying antirheumatic drugs. Depression was also found to be a strong independent predictor of worse health-related quality of life, more pain, more functional disability and less adherence to treatment. These findings underscore the necessity for regular depression screening in rheumatology practice and advocate for the incorporation of mental health interventions into the management of rheumatoid arthritis to enhance treatment outcomes.Keywords
This publication has 18 references indexed in Scilit:
- Psychological interventions for reducing depressive symptoms in rheumatoid arthritis patients: a systematic review and network meta-analysisPsychology, Health & Medicine, 2025
- Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritisRheumatology, 2024
- Health-related quality of life (HRQoL) loss associated with self-perceived anxiety/depression in seropositive rheumatoid arthritisClinical Rheumatology, 2024
- A qualitative survey on factors affecting depression and anxiety in patients with rheumatoid arthritis: a cross-sectional study in SyriaScientific Reports, 2024
- Sleep quality, anxiety, depression, and quality of life in rheumatoid arthritis patients and impact of disease activityEgyptian Rheumatology and Rehabilitation, 2024
- Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled TrialsRheumatology and Therapy, 2023
- Rheumatoid arthritis and depressionJoint Bone Spine, 2021
- Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease featuresRMD Open, 2020
- Depression has an impact on disease activity and health‐related quality of life in rheumatoid arthritis: A systematic review and meta‐analysisInternational Journal of Rheumatic Diseases, 2019
- Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective studyBMC Musculoskeletal Disorders, 2016